BRIEF-Cynapsus says its positive on its Phase 3 Parkinson's study

Mon Aug 15, 2016 6:14am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 15 (Reuters) - Cynapsus Therapeutics Inc :

* Cynapsus announces positive opinion from data and safety monitoring board on Phase 3 Parkinson's Disease clinical study allowing for at-home titration Source text for Eikon: Further company coverage: